Appendectomy

Asep Medical's Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis

Retrieved on: 
Tuesday, February 27, 2024

VANCOUVER, BC, Feb. 27, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that its proprietary gene expression signature for sepsis can provide an improved assessment of the severity of appendicitis in children.

Key Points: 
  • VANCOUVER, BC, Feb. 27, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that its proprietary gene expression signature for sepsis can provide an improved assessment of the severity of appendicitis in children.
  • The study found that the "diagnostic study of 71 patients with pediatric appendicitis using systems immunology methods revealed a mechanistic understanding of severe disease, indicating immune dysregulation similar to that observed in sepsis.
  • The study concluded that early diagnostics and management strategies for pediatric PA should be informed by underlying immune dysregulation and similarities to sepsis.
  • Based on the new potential benefits of this ER technology, we look forward to improving outcomes for children presenting with abdominal pain in the ER."

Global Surgical Robots Market Forecast Report to 2030 - Partner & Customer Ecosystem Competitive Index & Regional Footprints - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 24, 2024

The "Global Surgical Robots Market 2030 by Product Type, Application, End-user, and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Surgical Robots Market 2030 by Product Type, Application, End-user, and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints" report has been added to ResearchAndMarkets.com's offering.
  • Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.
  • The demand for these computer-assisted surgical systems is substantial, being utilized in open surgeries, laparoscopic procedures, and flexible endoscopic procedures.
  • One key trend in the Surgical Robots Market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into surgical robotic systems.

Global Surgical Robots Market Report 2024 - Projected at USD 7.3 Billion by 2030: Integration of AI & High Demand for Minimally Invasive Surgeries Propel North America to the Forefront

Retrieved on: 
Wednesday, January 24, 2024

Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.

Key Points: 
  • Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.
  • The use of medical robotic systems has become widespread in the fields of gynaecology and cosmetology, particularly for minimally invasive surgeries.
  • The demand for these computer-assisted surgical systems is substantial, being utilized in open surgeries, laparoscopic procedures, and flexible endoscopic procedures.
  • One key trend in the Surgical Robots Market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into surgical robotic systems.

New Report Highlights Extreme Price Variation for the Same Medical Procedures Within and Across Hospitals

Retrieved on: 
Wednesday, December 20, 2023

Within the same hospitals, prices vary by an average range of more than 10 times for the same procedures when comparing insurance plan negotiated rates and the discounted cash price.

Key Points: 
  • Within the same hospitals, prices vary by an average range of more than 10 times for the same procedures when comparing insurance plan negotiated rates and the discounted cash price.
  • When looking across different hospitals in the same state, prices vary by an average range of more than 31 times when comparing hospitals and insurance plan negotiated rates.
  • "Our study reveals wide-scale price variations of more than 10 times for the same care across health plans and 33 times across hospitals," said PRA Founder and Chairman Cynthia Fisher.
  • "The glaring price variations in Minnesota are a symptom of a larger, broken health care system.

Medical Simulation Global Market to Reach $4.1 Billion by 2027 at a CAGR of 13.68%

Retrieved on: 
Thursday, December 1, 2022

The global medical simulation market size reached US$ 1.9 Billion in 2021.

Key Points: 
  • The global medical simulation market size reached US$ 1.9 Billion in 2021.
  • Looking forward, the publisher expects the market to reach US$ 4.1 Billion by 2027, exhibiting a CAGR of 13.68% during 2021-2027.
  • Medical simulation uses body manikins, task trainers and virtual reality (VR)-based systems for laparoscopic, gynecological, cardiovascular, arthroscopic, spinal, endovascular, dental and eye simulation.
  • The publisher provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2022-2027.

Medical Simulation Global Market Report 2022: Increasing Awareness of the Benefits of Simulation-Based Medical Learning Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 25, 2022

The "Medical Simulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Simulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global medical simulation market size reached US$ 1.9 Billion in 2021.
  • Moreover, the increasing awareness regarding the benefits of simulation-based learning among the masses is providing a thrust to the market growth.
  • The publisher provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2022-2027.

Healthgrades Awards MemorialCare Hospitals from Los Angeles to Orange County Total of 44 Specialty Awards

Retrieved on: 
Monday, November 21, 2022

ORANGE COUNTY, Calif., Nov. 21, 2022 /PRNewswire/ -- MemorialCare's Saddleback Medical Center, Long Beach Medical Center, and Orange Coast Medical Center received a combined total of 44 health excellence awards in various specialties from Healthgrades, a leading resource that connects consumers, physicians, and health systems.

Key Points: 
  • MemorialCare Saddleback Medical Center, Long Beach Medical Center, and Orange Coast Medical Center were recognized with specialty health excellence awards by Healthgrades, a leading online resource for comprehensive information about physicians and hospitals.
  • ORANGE COUNTY, Calif., Nov. 21, 2022 /PRNewswire/ -- MemorialCare's Saddleback Medical Center , Long Beach Medical Center , and Orange Coast Medical Center received a combined total of 44 health excellence awards in various specialties from Healthgrades, a leading resource that connects consumers, physicians, and health systems.
  • "Everyone at MemorialCare is tremendously proud that each of our hospitals received numerous 2022 Healthgrades specialty awards," says Barry Arbuckle, President and CEO, MemorialCare.
  • Saddleback Medical Center was recognized for Excellence Awards for gastrointestinal care, gastrointestinal surgery, pulmonary care, and critical care.

Dune View Strategies Welcomes Dr. Anthony Coletta as a Partner

Retrieved on: 
Monday, October 31, 2022

PHILADELPHIA, Oct. 31, 2022 /PRNewswire/ -- Dune View Strategies today announced that Dr. Anthony V. Coletta, M.D., MBA, former CEO of Tandigm Health and former president of facilitated health networks and executive vice president of Independence Blue Cross, will be joining the strategic advisory firm as a partner.

Key Points: 
  • "Joining Dan and the Dune View team as partner is yet another amazing opportunity to help transform the healthcare landscape in our country."
  • "When I was considering candidates to join our team, Dr. Coletta was one of the first names to come to mind," said Hilferty, founder of Dune View Strategies.
  • Later this week, Dune View Strategies will co-host the inaugural HealthKey Summit in Philadelphia on November 2-4, 2022.
  • Dune View Strategies is a strategic advising firm that accelerates opportunity and growth for emerging healthcare companies.

HEALTHGRADES RECOGNIZES TOP U.S. HOSPITALS FOR EXCELLENCE ACROSS 17 SPECIALTY CARE AREAS

Retrieved on: 
Tuesday, October 25, 2022

"This year's Specialty Excellence Awards and Ratings empower consumers to make informed choices about where to find best-in-class specialty care."

Key Points: 
  • "This year's Specialty Excellence Awards and Ratings empower consumers to make informed choices about where to find best-in-class specialty care."
  • With tools like hospital ratings and awards, Healthgrades takes the guesswork out of choosing a hospital with top-notch specialty care servicesa decision that can mean the difference between life and death.
  • *To be eligible for a Specialty Excellence Award, hospitals must receive a rating in one or more of the 33 procedures and conditions included in the determination of the award.
  • To learn more about Healthgrades ratings and awards determination process, see the 2023 Specialty Excellence Awards and Ratings Methodology .

AFTER 30 YEARS -- NEW GUIDELINES FOR WEIGHT-LOSS SURGERY

Retrieved on: 
Friday, October 21, 2022

NEWBERRY, Fla., Oct. 21, 2022 /PRNewswire/ -- Two of the world's leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse metabolic surgery for patients with type 2 diabetes beginning at a body mass index (BMI) of 30, a measure of body fat based on a person's height and weight and one of several important screening criteria for surgery.

Key Points: 
  • "It's time for a change in thinking and in practice for the sake of patients.
  • But even without metabolic disease, the guidelines say weight-loss surgery should be considered starting at BMI 30 for people who do not achieve substantial or durable weight loss or obesity disease-related improvement using nonsurgical methods.
  • Roughly 1 to 2% of the world's eligible patient population get weight-loss surgery in any given year.
  • The ASMBS/IFSO Guidelines are just the latest in a series of new recommendations from medical groups calling for expanded use of metabolic surgery.